BioCentury
ARTICLE | Company News

GSK, UNC partner in HIV, launch newco Qura

May 12, 2015 2:17 AM UTC

GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) and the University of North Carolina partnered to establish a research center at the university's Chapel Hill, N.C., campus and launch newco Qura Therapeutics aimed at curing HIV infection.

GSK will send a group of scientists to the new HIV Cure research center at UNC and provide $4 million to the center annually for five years. GSK spokesperson Melinda Stubbee said the partners also formed jointly owned Qura to manage IP contributed by the partners; to attract non-academic grant funding; and to partner with other pharmas. ...